WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Technology Software Products Tuesday, October 23, 2018 
Add Press Release News | News Feeds Feeds | Email This News Email

Tay-Sachs Disease Forecast In 19 Major Markets 2018-2028: Risk Factors, Disease Diagnosis and Prognosis Along with Specific Variations by Geography and Ethnicity
Friday, August 10, 2018

DUBLIN, Aug. 10, 2018 /PRNewswire/ --

The "Tay-Sachs Disease Forecast In 19 Major Markets 2018-2028" report has been added to's offering.

Hexosaminidase A deficiency (HEX A deficiency) results in a group of neurodegenerative disorders caused by the dysfunctional activity of the specific glycosphingolipid GM2 ganglioside. The disease occurs when cell membrane components known as gangliosides, accumulate to toxic levels, particularly in neurons in the brain and spinal cord, leading to the destruction of neurons and interference with biological functions. The predominant HEX A deficiency is Tay-Sachs disease (TSD) with its common acute infantile variant, which begins around six months of age and usually results in death by the age of four. Alternative variants of the pathology are the juvenile and the adult-onset TSD types.

This report provides the current prevalent population for TSD disease across 19 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Czech Republic, Portugal, Russia, Turkey, Saudi Arabia, Japan, China, India, Australia, Brazil) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from our analysis team, patients with main phenotypes and multiple symptoms of TSD have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for TSD include:

    --  Visual problems
    --  Low muscle tone
    --  Seizures
    --  Neuromuscular abnormalities
    --  Speech disturbances
    --  Cerebellar dysfunctions/Impaired cognitive status

Reasons to buy

    --  Able to quantify patient populations in global TSD market to target the
        development of future products, pricing strategies and launch plans.
    --  Gain further insight into the prevalence of the subdivided types of TSD
        and identify patient segments with high potential.
    --  Delivery of more accurate information for clinical trials in study
        sizing and realistic patient recruitment for various countries.
    --  Provide a level of understanding on the impact from specific co-morbid
        conditions on TSD prevalent population.
    --  Identify sub-populations within TSD which require treatment.
    --  Gain an understanding of the specific markets that have the largest
        number of TSD patients.

Key Topics Covered:

    1. List Of Tables And Figures
    2. Introduction
    3. Cause Of The Disease
    4. Risk Factors & Prevention
    5. Diagnosis Of The Disease
    6. Variation By Geography/Ethnicity
    7. Disease Prognosis & Clinical Course
    8. Key Comorbid Conditions / Features Associated With The Disease
    9. Methodology For Quantification Of Patient Numbers
    10. Top-Line Prevalence For Tay-Sachs Disease
    11. Features Of Tay-Sachs Disease Patients
    12. Infantile Phenotype
    13. Juvenile Phenotype
    14. Adult (Lots) Phenotype
    15. Abbreviations Used In The Report
    16. Other Services & Solutions
    17. Reports & Publications
    18. Online Epidemiology Databases
    19. Online Pharmaceutical Pricing Database
    20. References
    21. Appendix

For more information about this report visit

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets

Email This News Email | Submit To Slashdot Slashdot | Submit To Digg | Submit To | News Feeds Feeds

Nav Hexagon Strengthens its Construction Solutions Portfolio for AEC (Architecture, Engineering, Construction) Market with Bricsys Acquisition | Oct 23, 2018
Nav Beijer Electronics Launches iX 2.40 SP1 - Taking EXTER and E1000 Applications to the Next Level | Oct 23, 2018
Nav GenomOncology announces GO Pathology Workbench in use by Emory Healthcare for Clinical Reporting | Oct 23, 2018
Nav Codewise Presents Revolutionary Traffic Distribution Automation Technology | Oct 23, 2018
Nav MetTel Wins Timmy Award for Best Tech Workplace for Diversity | Oct 23, 2018
Nav Epson Introduces WorkForce Pro WF-C500R Series with Replaceable Ink Pack System and Epson Print Admin Software Solution | Oct 23, 2018
Nav Airbiquity to Sponsor escar Europe 2018: World's Leading Automotive Cybersecurity Conference | Oct 23, 2018
Nav Global fixed broadband subscribers exceed one billion | Oct 23, 2018
Nav SAPĀ® Leonardo Unveils Latest Machine Learning and Analytics Updates | Oct 23, 2018
Nav Kinesis Money Partners With TicketSocket for Real-World Application of Gold-Based Currencies | Oct 23, 2018

Submit News | View More News View More News